14 March 2023 |
13 March 2023 |
Information regarding excess/all-cause mortality |
H2023020120 response (pdf, 1.9 MB) |
14 March 2023 |
10 March 2023 |
Information regarding the review of the Medicinal Cannabis Scheme |
H2023020072 response (pdf, 816 KB) |
14 March 2023 |
10 March 2023 |
Information related to the findings of the Cochrane study |
H2023020535 response (pdf, 218 KB) |
14 March 2023 |
09 March 2023 |
Information regarding adverse events following immunisation (AEFI) numbers |
H2023021044 response (pdf, 178 KB) |
14 March 2023 |
09 March 2023 |
Information regarding censorship on Manatū Hauora social media platforms |
H2023020146 response (pdf, 252 KB) |
14 March 2023 |
09 March 2023 |
Information regarding COVID-19 deaths |
H2023019972 response (pdf, 867 KB) |
14 March 2023 |
09 March 2023 |
Information regarding neurodiversity policies |
H2023020114 response (pdf, 3.4 MB) |
14 March 2023 |
09 March 2023 |
Information regarding the Medsafe's income and expenditure |
H2023020015 response (pdf, 186 KB) |
14 March 2023 |
08 March 2023 |
Information regarding rongoā Māori and the Therapeutic Products Bill |
H2023019571 response (pdf, 1.5 MB) |
14 March 2023 |
08 March 2023 |
Information regarding the budgets of Manatū Hauora and the Therapeutics Products Bill |
H2023020136 response (pdf, 194 KB) |
14 March 2023 |
06 March 2023 |
Information on deaths related to COVID-19 |
H2023019862 response (pdf, 214 KB) H2023019862 - Appendix 1 (xlsx, 21 KB) |
14 March 2023 |
06 March 2023 |
Information regarding myocarditis in COVID-19 patients |
H2023019062 response (pdf, 2.3 MB) |
14 March 2023 |
06 March 2023 |
Information regarding psychoactive substance licences |
H2023019601 response (pdf, 4.2 MB) |
07 March 2023 |
03 March 2023 |
Information regarding conscientious objection and abortion |
H2023020070 response (pdf, 182 KB) |
07 March 2023 |
03 March 2023 |
Information regarding health reforms and new health entities |
H2023019691 response (pdf, 247 KB) |
07 March 2023 |
03 March 2023 |
Information regarding Manatū Hauora commitment to environmental sustainability |
H2023019900 response (pdf, 1004 KB) |
07 March 2023 |
02 March 2023 |
Information regarding diversity and inclusion at Manatū Hauora |
H2023019801 response (pdf, 792 KB) |
07 March 2023 |
02 March 2023 |
Information regarding the World Health Organization (WHO) pandemic treaty |
H2023019923 response (pdf, 211 KB) |
07 March 2023 |
01 March 2023 |
Information regarding red meat consumption |
H2023019832 response (pdf, 215 KB) |
07 March 2023 |
28 February 2023 |
Information regarding exemptions to vaccine mandates |
H2023019241 response (pdf, 3 MB) |
07 March 2023 |
28 February 2023 |
Information regarding the 2015 Elective Health Target cost benefit analysis |
H2023019707 response (pdf, 1.1 MB) |
07 March 2023 |
27 February 2023 |
Information regarding attention deficit hyperactivity disorder (ADHD) |
H2023019935 response (pdf, 257 KB) |
07 March 2023 |
27 February 2023 |
Information regarding mental health costs |
H2023019752 response (pdf, 204 KB) |
07 March 2023 |
27 February 2023 |
Information regarding the listing of Adverse Effects Following Immunisation (AEFI) case numbers |
H2023020621 response (pdf, 207 KB) |
06 March 2023 |
03 March 2023 |
Information regarding rongoā Māori and the Therapeutic Products Bill |
H2023019574 response (pdf, 9.5 MB) |
27 February 2023 |
24 February 2023 |
Information regarding community water fluoridation and fluoridation levels |
H2023019906 response (pdf, 262 KB) |
27 February 2023 |
24 February 2023 |
Information regarding Ernst & Young (EY) contracts |
H2023019614 response (pdf, 275 KB) |
27 February 2023 |
24 February 2023 |
Information regarding rongoā Māori and the Therapeutic Products Bill |
H2023019575 response (pdf, 1.9 MB) |
27 February 2023 |
24 February 2023 |
Information related to climate change |
H2023020011 response (pdf, 5 MB) |
27 February 2023 |
24 February 2023 |
Information related to pandemic plans |
H2023020151 response (pdf, 251 KB) |
27 February 2023 |
23 February 2023 |
Information on health sector ministerial appointed boards or committees |
H2023019710 response (pdf, 224 KB) |
27 February 2023 |
23 February 2023 |
Information regarding Environmental Health Officers Qualifications Regulations 1993 |
H2023019425 response (pdf, 2.4 MB) |
27 February 2023 |
20 February 2023 |
Information on water fluoridation |
H2023019751 response (pdf, 200 KB) |
27 February 2023 |
25 January 2023 |
Information related to Facebook's takedown portal |
H2023018978 response (pdf, 241 KB) |
20 February 2023 |
17 February 2023 |
Information regarding COVID-19 reinfection |
H2023019427 response (pdf, 241 KB) |
20 February 2023 |
17 February 2023 |
Information regarding Ivermectin |
H2023019804 response (pdf, 2 MB) |
20 February 2023 |
17 February 2023 |
Information regarding natural health products |
H2023019499 response (pdf, 257 KB) |
20 February 2023 |
16 February 2023 |
Information regarding metformin and nitrosamine impurities |
H2023019058 response (pdf, 174 KB) |
20 February 2023 |
16 February 2023 |
Information relating to medical abortions |
H2022018711 response (pdf, 205 KB) |
16 February 2023 |
15 February 2023 |
Information on complaints made to the Registrar of Assisted Dying |
H2023019720 response (pdf, 1.3 MB) |
16 February 2023 |
15 February 2023 |
Information on nominations and appointments to the Medical Council of NZ |
H2023019661 response (pdf, 258 KB) |
16 February 2023 |
15 February 2023 |
Information regarding assisted dying service data and reporting |
H2023019911 response (pdf, 173 KB) |
16 February 2023 |
15 February 2023 |
Information regarding the Mpox vaccine |
H2023019666 response (pdf, 190 KB) |
16 February 2023 |
15 February 2023 |
Information related to the COVID-19 and National Immunisation Programme research round |
H2023019400 response (pdf, 788 KB) |
16 February 2023 |
15 February 2023 |
Information related to the End of Life Choice Act |
H2023019795 response (pdf, 179 KB) |
16 February 2023 |
14 February 2023 |
Information regarding the sale of tobacco imports |
H2023019423 response (pdf, 222 KB) |
16 February 2023 |
13 February 2023 |
Information regarding dispensing of mifepristone and misoprostol |
H2023019631 response (pdf, 166 KB) |
16 February 2023 |
13 February 2023 |
Information regarding lead contamination |
H2022018112 response (pdf, 10.2 MB) |
16 February 2023 |
13 February 2023 |
Information regarding the abortion services annual report |
H2023019870 response (pdf, 168 KB) |
16 February 2023 |
13 February 2023 |
Information regarding the Therapeutic Products Bill and the Medicinal Cannabis Scheme |
H2022018971 response (pdf, 229 KB) |
16 February 2023 |
13 February 2023 |
Information relating to the Dental Council |
H2023019301 response (pdf, 173 KB) H2023020487 response (pdf, 173 KB) |
16 February 2023 |
10 February 2023 |
Information regarding Group A Streptococcus |
H2023019243 response (pdf, 282 KB) |
16 February 2023 |
10 February 2023 |
Information regarding the End of Life Choice Act |
H2023019318 response (pdf, 1.6 MB) |
16 February 2023 |
09 February 2023 |
Information regarding the Medicines Adverse Reactions Committee |
H2023019684 response (pdf, 201 KB) |
15 February 2023 |
15 February 2023 |
Information regarding long COVID |
H2023019340 response (pdf, 1.2 MB) |
13 February 2023 |
13 February 2023 |
Information on COVID-19 and international arrivals from China |
H2023019200 response (pdf, 5.4 MB) |
09 February 2023 |
08 February 2023 |
Information regarding rongoā Māori and the Therapeutic Products Bill |
H2023019049 response (pdf, 5 MB) |
09 February 2023 |
07 February 2023 |
Information regarding adverse reactions to vaccinations during pregnancy |
H2023019257 response (pdf, 172 KB) |
09 February 2023 |
07 February 2023 |
Information regarding suicide prevention and social media |
H2022018206 response (pdf, 2.8 MB) |
09 February 2023 |
07 February 2023 |
Information regarding the World Health Organization’s (WHO) International Health Review Committee |
H2022018844 response (pdf, 1.4 MB) |
09 February 2023 |
07 February 2023 |
Information related to the Therapeutic Products Bill |
H2023019553 response (pdf, 230 KB) H2023019367 response (pdf, 229 KB) H2023019556 response (pdf, 210 KB) H2023019524 response (pdf, 267 KB) |
09 February 2023 |
31 January 2023 |
Information regarding the COVID-19 vaccination |
H2022018814 response (pdf, 172 KB) |
09 February 2023 |
31 January 2023 |
Information related to a RFP to survey the illicit tobacco market |
H2023019147 response (pdf, 1.9 MB) |
09 February 2023 |
30 January 2023 |
Information regarding adult dental health care |
H2022018202 response (pdf, 2.2 MB) |
09 February 2023 |
30 January 2023 |
Information related to Facebook's 'takedown portal' |
H2022018547 response (pdf, 263 KB) |
07 February 2023 |
07 February 2023 |
Information regarding COVID-19 vaccine purchasing agreements |
H2023019004 response (pdf, 170 KB) |
01 February 2023 |
27 January 2023 |
Information regarding COVID-19 vaccine efficacy |
H2022018675 response (pdf, 212 KB) |
01 February 2023 |
27 January 2023 |
Information regarding emergency department waiting times |
H2022018291 response (pdf, 6.1 MB) H2022018291 - Appendix 2 (xlsx, 51 KB) |
01 February 2023 |
27 January 2023 |
Information related to Principal Advisors at Manatū Hauora |
H2023018988 response (pdf, 2.3 MB) |
01 February 2023 |
26 January 2023 |
Information regarding drinking water data |
H2022018821 response (pdf, 228 KB) H2022018821 - Appendix 1 (xlsx, 245 KB) |
01 February 2023 |
25 January 2023 |
Information regarding face masks |
H2022018342 response (pdf, 277 KB) |
01 February 2023 |
24 January 2023 |
Information regarding guidelines for COVID-19 vaccination of children |
H2022018201 response (pdf, 225 KB) |
24 January 2023 |
18 January 2023 |
Information related to the COVID-19 vaccine |
H2022018490 response (pdf, 1.7 MB) |
24 January 2023 |
18 January 2023 |
Information related to the International Health Regulations (IHR) |
H2022015383 response (pdf, 23.5 MB) |
24 January 2023 |
17 January 2023 |
Information on the COVID-19 vaccine, testing and response budget |
H2022018361 response (pdf, 220 KB) |
24 January 2023 |
16 January 2023 |
Information on Pfizer Cumulative Analysis Report of PF-07302048 |
H2022018890 response (pdf, 194 KB) |
24 January 2023 |
16 January 2023 |
Information on the classification of cannabidiol |
H2022017633 response (pdf, 178 KB) |
24 January 2023 |
16 January 2023 |
Information on the Focus Group meetings for NEAC |
H2022017383 response (pdf, 8 MB) H2022017383 follow up response (pdf, 172 KB) H2022019313 response (pdf, 1 MB) |
24 January 2023 |
16 January 2023 |
Information regarding staffing at Manatū Hauora |
H2022017774 response (pdf, 234 KB) |
24 January 2023 |
30 November 2022 |
Information on the regulatory impact statement on regulating natural health products |
H2022016152 response (pdf, 211 KB) H2022017883 response (pdf, 2.2 MB) H2022017883 follow up response (pdf, 222 KB) |
16 January 2023 |
13 January 2023 |
Information on cannabidiol & tetrahydrocannabinol products |
H2022017793 response (pdf, 196 KB) |
16 January 2023 |
13 January 2023 |
Information on end-of-year functions at Manatū Hauora |
H2022017746 response (pdf, 255 KB) |
16 January 2023 |
12 January 2023 |
Information on social media management at Manatū Hauora |
H2022017765 response (pdf, 203 KB) |
16 January 2023 |
12 January 2023 |
Information regarding the Pfizer COVID-19 vaccine |
H2022018097 response (pdf, 177 KB) |
16 January 2023 |
12 January 2023 |
Information relating to antimicrobial resistance in fungal organisms |
H2022017744 response (pdf, 232 KB) |
16 January 2023 |
11 January 2023 |
Information on the communications team at Manatū Hauora |
H2022017745 response (pdf, 218 KB) |
16 January 2023 |
11 January 2023 |
Information regarding amendments to the Mental Health Act |
H2022017874 response (pdf, 2.4 MB) |
16 January 2023 |
11 January 2023 |
Information regarding the Pfizer COVID-19 vaccine |
H2022018695 response (pdf, 143 KB) |
16 January 2023 |
09 January 2023 |
Information regarding psychoactive substance licenses |
H2022017627 response (pdf, 177 KB) |
16 January 2023 |
23 December 2022 |
Information on working from home policy at Manatū Hauora |
H2022017741 response (pdf, 225 KB) |
16 January 2023 |
23 December 2022 |
Information regarding Manatū Hauora employee statistics |
H2022017605 response (pdf, 296 KB) |